Sponsor content

Unlocking the power of DNA-encoded libraries

HitGen’s advanced encoded library technology, including its recently released nonexclusive-use OpenDEL and macrocycle libraries, affords exciting opportunities for those involved in early-stage drug discovery around challenging targets. To download the full article, please sign in.

Go to the profile of HitGen Ltd
Nov 05, 2015
1
Page of
Go to the profile of HitGen Ltd

HitGen Ltd

HitGen Ltd is a life science company based in Chengdu, China. The company was founded by people with extensive scientific and managerial experience in pharmaceutical, CRO and related industries. The formation of the company has received major investment from a number of investors, and enterprise grant support from Chengdu High Tech Zone. We are an innovation-driven and customer-focused company. HitGen has established a unique platform for early drug discovery research. With a focus on hit identification and lead generation during the early phase of drug discovery R&D, HitGen aims to be a leading provider in progressing projects from target to leads stage. To this end HitGen has established a core platform consisting of high quality, large DNA encoded compound libraries and research capabilities in protein expression and purification, in-vitro screening and affinity selection, chemical library design and synthesis, and medicinal chemistry. HitGen also provides other biological reagents and services to support drug discovery research. The company’s headquarters is based in the Tianfu Life Science Park of the Chengdu High-Tech Industrial Development Zone, one of the earliest state-level industrial development zones in China.

Comments are disabled